摘要
背景:研究表明,细胞因子参与炎症性疾病和血管疾病的发展。 目的:本研究探讨转化生长因子β(TGFβ)、白细胞介素6(IL6)、肿瘤坏死因子α(TNFα)和干扰素γ(IFNγ)随血栓闭塞性脉管炎(TAO)症状进展的变化。 方法:本研究纳入了 80 名 TAO 患者,他们从 2012 年到 2016 年从 Alavi 医院血管和血管内研究中心选出。然后将他们分为三组:轻度(迁移性血栓性静脉炎、冷敏感性或雷诺现象、和皮肤变色)、中度(慢性溃疡、跛行和夜间足部灼痛)和重度(休息时疼痛和自发性坏疽)症状。采用ELISA法测定血清TGFβ、IL6、TNFα、IFNγ水平并进行组间比较。 结果:前三个主要症状是脉搏障碍(n = 76, 95.00%)、怕冷(n = 61, 76.25%)和跛行(n = 59, 73.75%)。协方差分析 (ANCOVA) 的比较显示,随着症状的严重程度从中度到重度阶段的增加,TGFβ 和 IL6 均失调;然而,这种变化并不显着(p > 0.05)。在多元逻辑回归模型中,与严重症状相比,存在中度症状时 TNFα 水平升高(p < 0.05)。 结论:可以得出结论,作为 T 辅助细胞的定义细胞因子产生谱的一部分,TNFα 可以显着参与 TAO 从中度到重度阶段的进展。
关键词: 细胞因子、横断面研究、体征和症状、血栓闭塞性脉管炎、ELISA、疾病。
Current Molecular Medicine
Title:Cytokine Analysis in Patients with Different Stages of Thromboangiitis Obliterans
Volume: 21 Issue: 9
关键词: 细胞因子、横断面研究、体征和症状、血栓闭塞性脉管炎、ELISA、疾病。
摘要:
Background: Studies suggest that cytokines are involved in the development of both inflammatory disorders and vascular diseases.
Objective: The changes in transforming growth factor β (TGFβ), interleukin 6 (IL6), tumor necrosis factor α (TNFα), and interferon γ (IFNγ) with the progression of the thromboangiitis obliterans (TAO) symptoms were investigated in this research.
Methods: This study included 80 patients with TAO, who were selected from the Vascular and Endovascular Research Center in Alavi Hospital, from the year 2012 to 2016. They were then categorized into three groups: Mild (migratory thrombophlebitis, cold sensitivity or Raynaud's phenomenon, and skin discoloration), moderate (chronic ulcers, claudication, and burning pain of the feet at night), and severe (pain at rest and spontaneous gangrene) symptoms. The serum levels of TGFβ, IL6, TNFα, and IFNγwere determined by the ELISA method and compared among the groups.
Results: The first three predominant symptoms were pulse disorder (n = 76, 95.00%), cold intolerance (n = 61, 76.25%), and claudication (n = 59, 73.75%). A comparison of the analysis of covariance (ANCOVA) revealed that both TGFβ and IL6 were dysregulated as the severity of the symptoms increased from the moderate to the severe stages; however, such changes were not significant (p > 0.05). In the multiple logistic regression model, increased TNFα levels were seen in the presence of moderate symptoms as compared to the severe ones (p < 0.05).
Conclusion: It could be concluded that TNFα, as part of the defining cytokineproduction profile of T helper cells, can be significantly involved in the progression of TAO from the moderate to the severe stages.
Export Options
About this article
Cite this article as:
Cytokine Analysis in Patients with Different Stages of Thromboangiitis Obliterans, Current Molecular Medicine 2021; 21 (9) . https://dx.doi.org/10.2174/1566524020666201120112828
DOI https://dx.doi.org/10.2174/1566524020666201120112828 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Carotid Intima-Media Thickness and Ezetimibe: The End of a Misunderstanding?]
Current Vascular Pharmacology The Future of Collateral Artery Research
Current Cardiology Reviews Traditional Chinese Medicine Network Pharmacology in Cardiovascular Precision Medicine
Current Pharmaceutical Design Reactive Oxygen Species in Pathogenesis of Atherosclerosis
Current Pharmaceutical Design Investigation on Risk Factor of Vascular Thrombotic Diseases in Patients with Obstructive Sleep Apnea Hypopnea Syndrome
Vascular Disease Prevention (Discontinued) Potential Targets for Intervention in Radiation-Induced Heart Disease
Current Drug Targets Structure-activity Relationships of Snake Toxins Targeting Platelet Receptors, Glycoprotein Ib-IX-V and Glycoprotein VI
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Recent Developments of C-Aryl Glucoside SGLT2 Inhibitors
Current Medicinal Chemistry Does Caffeine Affect Cardiovascular Responses?
Vascular Disease Prevention (Discontinued) A Review of the Relationships Between Endogenous Sex Steroids and Incident Ischemic Stroke and Coronary Heart Disease Events
Current Cardiology Reviews Photosensitizers for Photodynamic Therapy: Photochemistry in the Service of Oncology
Current Pharmaceutical Design Targeted Drug Delivery for Cardiovascular and Cerebrovascular Diseases
Current Drug Targets Effect of a Physical Activity Program on Serum Biochemical Parameters among the Elderly Women
Reviews on Recent Clinical Trials Clinically Relevant Pharmacokinetic Herb-drug Interactions in Antiretroviral Therapy
Current Drug Metabolism Diabetic Cardiomyopathy: Electromechanical Cellular Alterations
Current Vascular Pharmacology The Molecular Basis of the Interplay between Endothelin-1 and Nitric Oxide and its Relevance for Atherosclerosis and Arterial and Pulmonary Hypertension
Vascular Disease Prevention (Discontinued) Gene Therapy as a Novel Pharmaceutical Intervention for Stroke
Current Pharmaceutical Design Matrix Metalloproteinase (MMP)-7 Activates MMP-8 But Not MMP-13
Medicinal Chemistry Blood Pressure and White Matter Lesions in Patients with Vascular Disease: The SMART-MR Study
Current Neurovascular Research An Assessment of Patients Factors Effect on Prescriber Adherence to Ischemic Stroke Secondary Prevention Guidelines
Current Reviews in Clinical and Experimental Pharmacology